Abstract
Purpose
Pregnant patients present a unique challenge to cancer therapy. Due to the potential catastrophic implications related to teratogenic effects or pregnancy loss, oncologic management of this vulnerable patient group must be strategic and personalized.
Methods
This article will discuss the unique treatment approach to the pregnant cancer patient. This includes discussion of the role of imaging during staging, treatment, and follow-up with an emphasis on avoiding ionizing radiation when possible.
Results and Conclusion
Specific considerations and modifications to standard cancer treatments, including surgery and systemic therapies such as chemotherapy, immunotherapy, targeted and hormone therapies are crucial components of providing oncologic care to minimize negative effects to the mother and developing fetus. Radiation and proton therapy are also options that may be employed in specific circumstances. Finally, this article will address the long-term treatment effects of these therapies on future fertility.
Graphical Abstract
Similar content being viewed by others
References
New Drugs Raise Old Questions about Treating Cancer During Pregnancy. Available at: https://www.cancer.gov/news-events/cancer-currents-blog/2022/treating-cancer-pregnancy-new-drugs. NIH National Cancer Institute. Updated 5/25/22. Accessed July 22, 2022.
Hepner A, Negrini D, Hase EA, et al. Cancer during pregnancy: The oncologist overview. World J Oncol. 2019;10(1):28-34. doi:https://doi.org/10.14740/wjon1177
Vandenbroucke T, Verheecke M, Fumagalli M, Lok C, Amant F. Effects of cancer treatment during pregnancy on fetal and child development. Lancet Child Adolesc Health. 2017;1(4):302-310. doi:https://doi.org/10.1016/S2352-4642(17)30091-3
Botha MH, Rajaram S, Karunaratne K. Cancer in Pregnancy, FIGO Cancer Report 2018. Int J Gynecol Obstet 2018; 143 (Suppl. 2): 137–142
Maggen C, Wolters VERA, Cardonick E, Fumagalli M, Halaska MJ, Lok CAR, de Haan J, Van Tornout K, Van Calsteren K, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP). Pregnancy and Cancer: the INCIP Project. Curr Oncol Rep. 2020 Feb 5;22(2):17. doi: https://doi.org/10.1007/s11912-020-0862-7.
Dalmartello M, Negri E, La Vecchia C, et al. Frequency of Pregnancy-Associated Cancer: A Systematic Review of Population-Based Studies. Cancers 2020, 12(6), 1356. https://doi.org/10.3390/cancers12061356
Amant F, Han SN, Gziri MM, Vandenbroucke T, Verheecke M, Van Calsteren K. Management of cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29(5):741-753. doi:https://doi.org/10.1016/j.bpobgyn.2015.02.006
Silverstein J, Post AL, Chien AJ, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020;16(9):545-557. doi:https://doi.org/10.1200/OP.20.00077
Moran BJ, Yano H, Al Zahir N, Farquharson M. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol. 2007;8(6):536-544. doi:https://doi.org/10.1016/S1470-2045(07)70171-7
Córdoba O, Llurba E, Saura C, et al. Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes. Breast. 2013;22(4):515-519. doi:https://doi.org/10.1016/j.breast.2012.10.005
Dean G, Jacobs AR, Goldstein RC, Gevirtz CM, Paul ME. The safety of deep sedation without intubation for abortion in the outpatient setting. J Clin Anesth. 2011;23(6):437-442. doi:https://doi.org/10.1016/j.jclinane.2011.05.001
Kuczkowski KM. The safety of anaesthetics in pregnant women. Expert Opin Drug Saf. 2006;5(2):251-264. doi:https://doi.org/10.1517/14740338.5.2.251
Wolters V, Heimovaara J, Maggen C, et al. Management of pregnancy in women with cancer. Int J Gynecol Cancer. 2021;31(3):314-322. doi:https://doi.org/10.1136/ijgc-2020-001776
American College of Obstetrics and Gynecology. ACOG practice bulletin. Perinatal care at the threshold of viability. Number 38 September 2002 American College of Obstetrics and Gynecology. Int J Gynaecol Obstet. 2002. 79(2):181–8. Doi: https://doi.org/10.1016/s0020-7292(02)00328-4
Ecker JL, Kaimal A, Mercer BM, et al. Periviable birth. Obstetric Care Consensus No. 6. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e187–99.
Nonobstetric surgery during pregnancy. ACOG Committee Opinion No. 775. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2019;133:e285–6.
Pasternak B, Svanström H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes [published correction appears in N Engl J Med. 2013 May 30;368(22):2146]. N Engl J Med. 2013;368(9):814-823. doi:https://doi.org/10.1056/NEJMoa1211035
Anderka M, Mitchell AA, Louik C, et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94(1):22-30. doi:https://doi.org/10.1002/bdra.22865
Borgers, J., Heimovaara J, Cardonick E et al, Immunotherapy for cancer treatment during pregnancy. Lancet Oncology, 2021. 22.
Amant F, Berveiller P, Boere IA, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601-1612. doi:https://doi.org/10.1093/annonc/mdz228.
Esposito S, Tenconi R, Preti V, Groppali E, Principi N. Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes. Medicine (Baltimore). 2016;95(38):e4899. doi:https://doi.org/10.1097/MD.0000000000004899.
Schwab R, Anic K, Hasenburg A. Cancer and pregnancy: A comprehensive review. Cancers (Basel). 2021;13(12):3048. Published 2021 Jun 18. doi:https://doi.org/10.3390/cancers13123048
Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. Lancet. 2012;379(9815):570-579. doi:https://doi.org/10.1016/S0140-6736(11)61092-1
Poggio F, Tagliamento M, Pirrone C, et al. Update on the management of breast cancer during pregnancy. Cancers (Basel). 2020;12(12):3616. Published 2020 Dec 3. doi:https://doi.org/10.3390/cancers12123616
Mittra A, Naqash AR, Murray JH, et al. Outcomes of pregnancy during immunotherapy treatment for cancer: Analysis of clinical trials sponsored by the National Cancer Institute. Oncologist. 2021;26(10):e1883-e1886. doi:https://doi.org/10.1002/onco.13941
Duma N, Lambertini M. It is time to talk about fertility and immunotherapy. Oncologist. 2020 Apr;25(4):277-278.
Choi J, Lee SY. Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors. Immune Netw. 2020 Feb 17;20(1):e9. doi: https://doi.org/10.4110/in.2020.20.e9. PMID: 32158597; PMCID: PMC7049586.
Lavacchi D, Roviello G, D'Angelo A. Tumor-agnostic teatment for cancer: When how is better than where. Clin Drug Investig. 2020;40(6):519-527. doi:https://doi.org/10.1007/s40261-020-00915-5
Lambertini M, Peccatori FA, Azim HA Jr. Targeted agents for cancer treatment during pregnancy. Cancer Treat Rev. 2015;41(4):301-309. doi:https://doi.org/10.1016/j.ctrv.2015.03.001
Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(2):349-357. doi:https://doi.org/10.1007/s10549-012-2368-y
Perrotta K, Kiernan E, Bandoli G, Manaster R, Chambers C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol Adv Pract. 2021;5(1):rkaa074. doi:https://doi.org/10.1093/rap/rkaa074
Durrani S, Akbar S, Heena H. Breast Cancer During Pregnancy. Cureus. 2018 Jul 8;10(7):e2941. doi: https://doi.org/10.7759/cureus.2941.
Buonomo B, Brunello A, Noli S, et al. Tamoxifen exposure during pregnancy: A systematic review and three more cases. Breast Care (Basel). 2020;15(2):148-156. doi:https://doi.org/10.1159/000501473
Wang X, Poenisch F, Sahoo N, et al. Spot scanning proton therapy minimizes neutron dose in the setting of radiation therapy administered during pregnancy. J Appl Clin Med Phys. 2016;17(5):366-376. Published 2016 Sep 8. doi:https://doi.org/10.1120/jacmp.v17i5.6327
Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6(5):328-333. doi:https://doi.org/10.1016/S1470-2045(05)70169-8
Boere I, Lok C, Poortmans P, et al. Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities. Best Practice & Research Clinical Obstetrics and Gynaecolog. 2022; 82: 46-59
National Cancer Institute. “Breast Cancer Treatment During Pregnancy.” Available at: https://www.cancer.gov/types/breast/hp/pregnancy-breast-treatment-pdq#_13. Updated March 19, 2019. Accessed July 24, 2022.
Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193-199. doi:https://doi.org/10.7150/ijms.3635
Corradini S, Alongi F, Andratschke N, et al. MR-guidance in clinical reality: Current treatment challenges and future perspectives. Radiat Oncol. 2019;14(1):92. Published 2019 Jun 3. doi:https://doi.org/10.1186/s13014-019-1308-y
Mazzola R, Corradini S, Eidemüeller M, et al. Modern radiotherapy in cancer treatment during pregnancy. Crit Rev Oncol Hematol. 2019;136:13-19. doi:https://doi.org/10.1016/j.critrevonc.2019.02.002
The National Association for Proton Therapy. Available at: https://www.proton-therapy.org/. Updated 2022. Accessed July 26, 2022.
Oeck S, Szymonowicz K, Wiel G, et al. Relating linear energy transfer to the formation and resolution of DNA repair foci after irradiation with equal doses of X-ray photons, plateau, or bragg-peak protons. Int J Mol Sci. 2018;19(12):3779. Published 2018 Nov 28. doi:https://doi.org/10.3390/ijms19123779
Gulliford SL, Prise KM. Relative biological effect/linear energy transfer in proton beam therapy: A primer. Clin Oncol (R Coll Radiol). 2019;31(12):809-812. doi:https://doi.org/10.1016/j.clon.2019.06.009
Heimovaara JH, Blommaert J, Free J, et al. Proton therapy of a pregnant patient with nasopharyngeal carcinoma. Clin Transl Radiat Oncol. 2022;35:33-36. Published 2022 May 4. doi:https://doi.org/10.1016/j.ctro.2022.04.014
Geng C, Moteabbed M, Seco J, et al. Dose assessment for the fetus considering scattered and secondary radiation from photon and proton therapy when treating a brain tumor of the mother. Phys Med Biol. 2016;61(2):683-695. doi:https://doi.org/10.1088/0031-9155/61/2/683
Jha P, Pōder L, Glanc P, et al. Imaging Cancer in Pregnancy. Radiographics. 2022;42(5):1494-1513. doi:https://doi.org/10.1148/rg.220005
Gibelli B, Zamperini P, Proh M, Giugliano G. Management and follow-up of thyroid cancer in pregnant women. Acta Otorhinolaryngol Ital. 2011 Dec;31(6):358-65. PMID: 22323846
Khaled H, Al Lahloubi N, Rashad N. A review on thyroid cancer during pregnancy: Multitasking is required. J Adv Res. 2016 Jul;7(4):565-70. doi: https://doi.org/10.1016/j.jare.2016.02.007. Epub 2016 Mar 2. PMID: 27408758
National Cancer Institute. Fertility issues in women and girls with cancer. Available at: https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-women. Updated 2/24/20. Accessed September 3, 2022.
Shandley LM, Spencer JB, Fothergill A, et al. Impact of tamoxifen therapy on fertility in breast cancer survivors. Fertil Steril. 2017;107(1):243-252.e5. doi:https://doi.org/10.1016/j.fertnstert.2016.10.020
Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73(5):1304-1312. doi:https://doi.org/10.1016/j.ijrobp.2008.12.016
Waimey KE, Smith BM, Confino R, Jeruss JS, Pavone ME. Understanding fertility in young female cancer patients. J Womens Health (Larchmt). 2015;24(10):812-818. doi:https://doi.org/10.1089/jwh.2015.5194
Teh WT, Stern C, Chander S, Hickey M. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int. 2014;2014:482968. doi:https://doi.org/10.1155/2014/482968
Kumar R, De Jesus O. Radiation effects on the fetus. 2022. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
Bates GE, Taub RN, West H. Fertility and cancer treatment. JAMA Oncol. 2016;2(2):284. doi:https://doi.org/10.1001/jamaoncol.2015.4143
Brännström M, Dahm-Kähler P. Uterus transplantation and fertility preservation. Best Pract Res Clin Obstet Gynaecol. 2019;55:109-116. doi:https://doi.org/10.1016/j.bpobgyn.2018.12.006
Baylor Scott & White Health. https://www.bswhealth.com/treatments-and-procedures/uterus-transplant. Updated 2022. Accessed Sept 7, 2022.
Funding
Melissa McGettigan No financial disclosures. Kerry Thomas No financial disclosures relevant to this manuscript; equity stockholder MedTronic, UnitedHealthcare, AbbVie, Amgen. Amita Kamath: No financial disclosures.
Author information
Authors and Affiliations
Contributions
All authors contributed to the design, material preparation, first draft of the manuscript. All authors commented on drafts, read, and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Melissa McGettigan contributed to the article by Jha P, et al. Imaging Cancer in Pregnancy. RadioGraphics 2022 42:5. Melissa McGettigan is an unpaid committee member of the Society of Abdominal Radiology Uterine and Ovarian Cancer Disease Focused Panel. The authors do not claim any relevant conflicts of interest and have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
McGettigan, M., Thomas, K. & Kamath, A. Cancer in pregnancy: treatment effects. Abdom Radiol 48, 1774–1783 (2023). https://doi.org/10.1007/s00261-022-03787-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03787-9